Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer-Reference-Cited by-同舟云学术

Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer

Published:2012-09-14 Issue:11b Volume:110 Page:E667-E672
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Dai Bo,Qu YuanYuan,Kong YunYi,Ye DingWei,Yao XuDong,Zhang ShiLin,Wang ChaoFu,Zhang HaiLiang,Yang WeiYi

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11465.x/fullpdf

Reference26 articles.

1. Testosterone and prostate cancer: revisiting old paradigms;Isbarn;Eur Urol,2009

2. Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancer;Morgentaler;Cancer,2011

3. Occult prostate cancer in men with low serum testosterone levels;Morgentaler;JAMA,1996

4. Testosterone and prostate cancer: an historical perspective on a modern myth;Morgentaler;Eur Urol,2006

5. Endogenous sex hormones and the risk of prostate cancer: a prospective study;Weiss;Int J Cancer,2008

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aggressive Prostate Cancer After a 14-Year Gonadotropin Therapy: A Case Report;Cureus;2024-06-19

2. Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix;The Prostate;2024-02-27

3. Anti-Müllerian hormone: a novel biomarker for aggressive prostate cancer? Emerging evidence from a prospective study of radical prostatectomies;Hormones;2023-12-21

4. SERUM TESTOSTERONE AS A MARKER OF RESPONSE TO ANDROGEN DEPRIVATION THERAPY IN METASTATIC PROSTATE CANCER;Asian Journal of Pharmaceutical and Clinical Research;2023-08-07

5. Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants;BJUI Compass;2023-01-09